Analysis of 6.4 million SARS-CoV-2 genomes identifies mutations associated with fitness.


Journal

medRxiv : the preprint server for health sciences
Titre abrégé: medRxiv
Pays: United States
ID NLM: 101767986

Informations de publication

Date de publication:
16 Feb 2022
Historique:
entrez: 23 2 2022
pubmed: 24 2 2022
medline: 24 2 2022
Statut: epublish

Résumé

Repeated emergence of SARS-CoV-2 variants with increased fitness necessitates rapid detection and characterization of new lineages. To address this need, we developed PyR A Bayesian hierarchical model of all SARS-CoV-2 viral genomes predicts lineage fitness and identifies associated mutations.

Identifiants

pubmed: 35194619
doi: 10.1101/2021.09.07.21263228
pmc: PMC8863165
pii:
doi:

Types de publication

Preprint

Langues

eng

Subventions

Organisme : NIAID NIH HHS
ID : R37 AI147868
Pays : United States

Commentaires et corrections

Type : UpdateIn

Références

J Virol. 2009 Oct;83(19):10314-8
pubmed: 19640993
mBio. 2013 Aug 13;4(4):
pubmed: 23943763
Cell. 2020 Sep 3;182(5):1295-1310.e20
pubmed: 32841599
Cell Host Microbe. 2021 Jan 13;29(1):44-57.e9
pubmed: 33259788
Proc Natl Acad Sci U S A. 2009 Mar 3;106(9):3484-9
pubmed: 19208801
Elife. 2014 Sep 25;3:
pubmed: 25255213
Nature. 2020 Jun;582(7811):289-293
pubmed: 32272481
Nucleic Acids Res. 2022 Jan 7;50(D1):D883-D887
pubmed: 34396391
Euro Surveill. 2021 Jun;26(24):
pubmed: 34142653
Sci Rep. 2020 Aug 19;10(1):14004
pubmed: 32814791
Nat Commun. 2021 Feb 2;12(1):743
pubmed: 33531496
Cell. 2021 Jun 24;184(13):3426-3437.e8
pubmed: 33991487
Nature. 2021 Nov;599(7883):91-95
pubmed: 34707284
Acta Pharmacol Sin. 2020 Sep;41(9):1141-1149
pubmed: 32747721
Viruses. 2020 Jan 15;12(1):
pubmed: 31952352
Science. 2021 Sep 03;373(6559):1142-1146
pubmed: 34315827
Nat Commun. 2021 May 11;12(1):2642
pubmed: 33976134
Nature. 2020 Aug;584(7819):154-156
pubmed: 32438371
Virus Evol. 2022 May 11;8(1):veac021
pubmed: 35573973
Cell. 2020 Aug 20;182(4):812-827.e19
pubmed: 32697968
Stat Sci. 2022 May;37(2):162-182
pubmed: 36034090
Science. 2021 Apr 9;372(6538):
pubmed: 33658326
Cell. 2021 Jan 7;184(1):184-193.e10
pubmed: 33232691
Clin Chem. 2004 Jun;50(6):988-95
pubmed: 15054081
Glob Chall. 2017 Jan 10;1(1):33-46
pubmed: 31565258
Nat Genet. 2021 Jun;53(6):809-816
pubmed: 33972780
Science. 2021 Dec 24;374(6575):1626-1632
pubmed: 34735219
Cell. 2020 Oct 29;183(3):739-751.e8
pubmed: 32991842
Mol Biol Evol. 2021 Dec 9;38(12):5819-5824
pubmed: 34469548
Nature. 2021 May;593(7858):266-269
pubmed: 33767447
N Engl J Med. 2020 Dec 3;383(23):2291-2293
pubmed: 33176080
Nat Commun. 2021 Mar 29;12(1):1936
pubmed: 33782395
Nat Microbiol. 2020 Nov;5(11):1403-1407
pubmed: 32669681
Cell. 2020 Sep 17;182(6):1560-1573.e13
pubmed: 32783916
J Virol. 2005 Nov;79(21):13399-411
pubmed: 16227261

Auteurs

Fritz Obermeyer (F)

Broad Institute of MIT and Harvard; 415 Main Street, Cambridge, MA 02142, USA.
Pyro Committee, Linux AI & Data Foundation; 548 Market St San Francisco, California 94104.

Martin Jankowiak (M)

Broad Institute of MIT and Harvard; 415 Main Street, Cambridge, MA 02142, USA.
Pyro Committee, Linux AI & Data Foundation; 548 Market St San Francisco, California 94104.

Nikolaos Barkas (N)

Broad Institute of MIT and Harvard; 415 Main Street, Cambridge, MA 02142, USA.

Stephen F Schaffner (SF)

Broad Institute of MIT and Harvard; 415 Main Street, Cambridge, MA 02142, USA.
Department of Organismic and Evolutionary Biology, Harvard University; Cambridge, MA 02138, USA.
Department of Immunology and Infectious Diseases, Harvard T. H. Chan School of Public Health, Harvard University; Boston, MA, USA.

Jesse D Pyle (JD)

Broad Institute of MIT and Harvard; 415 Main Street, Cambridge, MA 02142, USA.

Lonya Yurkovetskiy (L)

Program in Molecular Medicine, University of Massachusetts Medical School; Worcester, MA 01605, USA.

Matteo Bosso (M)

Program in Molecular Medicine, University of Massachusetts Medical School; Worcester, MA 01605, USA.

Daniel J Park (DJ)

Broad Institute of MIT and Harvard; 415 Main Street, Cambridge, MA 02142, USA.

Mehrtash Babadi (M)

Broad Institute of MIT and Harvard; 415 Main Street, Cambridge, MA 02142, USA.

Bronwyn L MacInnis (BL)

Broad Institute of MIT and Harvard; 415 Main Street, Cambridge, MA 02142, USA.
Department of Immunology and Infectious Diseases, Harvard T. H. Chan School of Public Health, Harvard University; Boston, MA, USA.
Massachusetts Consortium on Pathogen Readiness; Boston, MA 02115, USA.

Jeremy Luban (J)

Broad Institute of MIT and Harvard; 415 Main Street, Cambridge, MA 02142, USA.
Program in Molecular Medicine, University of Massachusetts Medical School; Worcester, MA 01605, USA.
Massachusetts Consortium on Pathogen Readiness; Boston, MA 02115, USA.
Ragon Institute of MGH, MIT, and Harvard; 400 Technology Square, Cambridge, MA 02139, USA.

Pardis C Sabeti (PC)

Broad Institute of MIT and Harvard; 415 Main Street, Cambridge, MA 02142, USA.
Department of Organismic and Evolutionary Biology, Harvard University; Cambridge, MA 02138, USA.
Department of Immunology and Infectious Diseases, Harvard T. H. Chan School of Public Health, Harvard University; Boston, MA, USA.
Massachusetts Consortium on Pathogen Readiness; Boston, MA 02115, USA.
Howard Hughes Medical Institute; 4000 Jones Bridge Rd, Chevy Chase, MD 20815, USA.

Jacob E Lemieux (JE)

Broad Institute of MIT and Harvard; 415 Main Street, Cambridge, MA 02142, USA.
Division of Infectious Diseases, Massachusetts General Hospital; Boston, MA, USA.

Classifications MeSH